We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PLRX icon
401
Pliant Therapeutics
PLRX
$66.3M
$66.3M $1.07 4.46%
XBIT icon
402
XBiotech
XBIT
$65.5M
$65.5M $2.15 2.27%
SPRO icon
403
Spero Therapeutics
SPRO
$64.6M
$64.6M $1.11 1.77%
APLM icon
404
Apollomics
APLM
$64.4M
$64.4M $22.11 7.95%
BOLD
405
Boundless Bio
BOLD
$64.1M
$64.1M $2.82 0.36%
LONA
406
LeonaBio Inc
LONA
$64M
$64M $6.79 6.22%
ELOX
407
Eloxx Pharmaceuticals
ELOX
$60.6M
$60.6M $17.63 3.4%
RNTX
408
Rein Therapeutics
RNTX
$60.6M
$60.6M $0.7021 0.76%
HRTX icon
409
Heron Therapeutics
HRTX
$60.3M
$60.3M $0.3178 1.21%
INKT icon
410
MiNK Therapeutics
INKT
$59.1M
$59.1M $11.59 1.58%
XLO icon
411
Xilio Therapeutics
XLO
$59.1M
$59.1M $8.98 0.55%
DWTX
412
Dogwood Therapeutics
DWTX
$57.8M
$57.8M $1.70 1.73%
EXOZ
413
eXoZymes Inc
EXOZ
$57.2M
$57.2M $6.16 6.38%
INMB icon
414
INmune Bio
INMB
$56.9M
$56.9M $2.05 9.29%
IMA
415
ImageneBio Inc
IMA
$56M
$56M $4.93 0.2%
HYFT
416
MindWalk Holdings
HYFT
$53.2M
$53.2M $1.13 2.59%
HYPD
417
Hyperion DeFi Inc
HYPD
$50.8M
$50.8M $3.27 0.61%
TVGN icon
418
Tevogen Inc
TVGN
$50.8M
$50.8M $7.80 0.65%
TIL icon
419
Instil Bio
TIL
$48.7M
$48.7M $7.18 0.42%
IMMP
420
Immutep
IMMP
$48.2M
$48.2M $0.3270 1%
ELTX icon
421
Elicio Therapeutics
ELTX
$46.5M
$46.5M $1.77 11.1%
GRCE
422
Grace Therapeutics
GRCE
$45M
$45M $2.14 4.04%
HOWL icon
423
Werewolf Therapeutics
HOWL
$44.7M
$44.7M $0.9190 6.22%
ANVS icon
424
Annovis Bio
ANVS
$44.4M
$44.4M $1.04 7.14%
MGX icon
425
Metagenomi Therapeutics
MGX
$43.4M
$43.4M $1.15 0.86%
15 16
17
18 19

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.